Technetium-99m-MIBI uptake in small cell lung cancer

Journal of Nuclear Medicine

Volumn 39, Issue 1, 1998, Pages 91-94

  Bom, Hee Seung ^a   Kim, Young Chul ^a   Song, Ho Cheon ^a   Min, Jung Jun ^a   Kim, Ji Yeul ^a   Park, Kyung Ok ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Chemotherapy; Small cell lung cancer; Technetium 99m MIBI

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; LUNG SMALL CELL CANCER; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE DISTRIBUTION; REMISSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031881745     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ihde DC. Chemotherapy of lung cancer. N Engl J Med 1992;327:1434-1441.
2. Deuchars KL, Ling V. P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin Oncol 1989;16:156-165.
3. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-984.
4. Moretti JL, Caglar M, Boaziz C, Caillat-Vigneron N, Morere JF. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer? Eur J Nucl Med 1995;22:177-180.
5. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-214.
6. Waxman AD. Thallium-201 and technetium-99m methoxyisobutyl isonitrile (MIBI) in nuclear oncology. In: Sandler MP, Coleman RE, Wackers FJT, Patton JA, Gottschalk A, Hoffer PB, eds. Diagnostic nuclear medicine, 3rd ed. Baltimore: Williams and Wilkins 1996;1261-1274.
7. Scopinaro F, Schillaci O, Scarpini M, et al. Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 1994;21:984-987.
8. Harris AL, Hochhauser D. Mechanisms of multidrug resistance in cancer treatment. Acta Oncologica 1992;31:205-213.
9. Crankshaw C, Piwnica-Worms D. Tc-99m sestamibi may be a transport substrate of the human multidrug resistance-associated protein (MRP) [Abstract]. J Nucl Med 1996;37:247P.
10. Kapucu LO, Akyuz C, Vural G, et al. The value of MIBI scintigraphy in predicting the prognosis in pediatric patients with lymphoma [Abstract]. J Nucl Med 1996;37:139P.
11. Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM. Characterization of multidrug-resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 1995;34:12210-12220.
12. Hassan I, Sahweel C, Constantinides A, et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989;14:333-340.
13. Lebouthillier G, Taillefer R, Lambert R, et al. Detection of primary lung cancer with Tc-99m MIBI [Abstract]. J Nucl Med 1989;34:140P.
14. Luker GD, Fracasso PM, Dobkin J, Piwnica-Worms D. Modulation of the multidrug-resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo. J Nucl Med 1997;38:369-372.
15. Wackers FJ, Berman D, Maddahi J, et al. Technetium-99m-hexakis 2-methoxy isobutilisonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-311.
16. Yamamoto Y, Nishiyama Y, Fukynaga K, Satoh K, Takashima H, Tanabe M. Evaluation of Tc-99m MIBI to predict chemotherapeutic response of patients with small cell lung cancer [Abstract]. Ann Nucl Med 1996;10(suppl):S137.
17. Jorgensen LG, Osterlind K, Hansen HH, Cooper EH. Serum neuron-specific enolase (S-NSE) in progressive small cell lung cancer (SCLC). Br J Cancer 1994;70:759-761.
18. Johnson PW, Joel SP, Love S, et al. Tumor markers for prediction of survival and monitoring of remission in small cell lung cancer. Br J Cancer 1993;67:760-766.
19. Arpin D, Trillet-Lenoir V, Lasset C, et al. Value of C-reactive protein determination in small cell lung cancer. Bull Cancer 1993;80:1063-1068.